Navigation Links
Elsevier acquires oncology journal portfolio from Cancer Information Group
Date:2/2/2011

New York, 2 February, 2011 - Elsevier (www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today that it acquired the oncology portfolio of journals previously published by CIG Media Group LP., (operated as Cancer Information Group). The journals publish peer-reviewed, disease specific original research and review articles that disseminate cutting-edge data to physicians, medical researchers and health care professionals.

"These journals provide an excellent addition to Elsevier's oncology portfolio and will further enhance the depth and quality of oncology content published by Elsevier," said Glen P. Campbell, Executive Vice President, Global Medical Research, for Elsevier. "We look forward to working with the editorial teams and to leveraging Elsevier's global resources and market-leading online platforms for the continued development and growth of the quality, international profile and visibility of these prestigious journals."

The specific journal titles are: Clinical Breast Cancer, Clinical Lung Cancer, Clinical Lymphoma Myeloma & Leukemia, Clinical Colorectal Cancer, Clinical Ovarian Cancer, and Clinical Genitourinary Cancer.

"Authors will benefit from the upcoming release of enhanced online manuscript submission and review systems for the journals, as well as the range of author support tools provided by Elsevier," said Campbell.


'/>"/>

Contact: Tom Reller
T.Reller@elsevier.com
215-239-3508
Elsevier
Source:Eurekalert

Page: 1

Related medicine news :

1. Elsevier Foundation announces 2010 grants for libraries in developing countries
2. Elsevier launches innovative online radiology board review product
3. Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology
4. Elsevier/MC Strategies and AORN launch perioperative nursing skills collection
5. Elseviers BrainNavigator 3.0 reflects the next step in enhancing neurological research
6. Elsevier launches new journal: Developmental Cognitive Neuroscience
7. Elsevier introduces SciVerse, an innovative platform for accelerating science
8. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
9. Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages
10. Elsevier partners with Helinet to strengthen consortiums leadership in health sciences education
11. Elsevier partners with ASRT to provide multimedia educational modules through Mosbys Imaging Suite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: